The name derives from Saponaria officinalis (soapwort), a European herb whose roots were historically used as a lathering agent , a property that reflects saponins' ability to lower surface tension in aqueous solutions. Two principal structural classes are recognised: triterpenoid saponins, built on a 30-carbon oleanane, ursane, or dammarane skeleton, and steroidal saponins, derived from a 27-carbon spirostane or furostane framework. This structural distinction influences how individual saponins behave chemically and how they interact with biological membranes.
Saponins are widely distributed across the plant kingdom. Notable dietary sources include legumes (Glycyrrhiza spp., soy, chickpeas), quinoa (Chenopodium quinoa), and various members of the Araliaceae family. Their amphiphilic character allows them to associate with membrane cholesterol, which is one mechanism proposed to explain their membrane-disrupting activity , a property that has attracted attention in adjuvant chemistry, particularly in the development of experimental vaccine formulations such as the ISCOM (immune-stimulating complex) platform.
Research into saponin pharmacology is active but carries important caveats. Much of the published mechanistic data comes from in vitro or rodent models; extrapolation to human physiology requires caution. The Cochrane and broader peer-review literature consistently note that clinical evidence for most individual plant saponins remains limited in scope and quality. Classification of saponin-containing plant extracts under the Australian Poisons Standard (the Standard for the Uniform Scheduling of Medicines and Poisons, administered by the TGA) varies by species and intended use; some preparations require assessment under the Complementary Medicines framework before supply.
Because saponins can interact with cell membranes and affect the absorption of co-administered compounds, their presence in botanical preparations is considered relevant to product safety profiling. Regulatory assessment of saponin-containing ingredients by the Therapeutic Goods Administration (TGA) follows standard evidence requirements for listed and registered complementary medicines, with no specific scheduling applying to the compound class as a whole absent other concerns.
Sources: